Corporate News     21-Apr-23
REC transfers KPSI1 Transmission to Megha Engineering & Infrastructures
REC has concluded the sale and transfer of KPSI1 Transmission to Megha Engineering & Infrastructures, the successful bidder selected through tariff based competitive bidding process for "Transmission scheme for injection beyond 3 GW RE power at Khavda PS1 (KPS1) " on 20 April 2023.

Hence, with effect from the aforesaid date, the above project specific SPV is not a subsidiary REC.

Previous News
  REC to table results
 ( Corporate News - 05-May-25   14:51 )
  Board of REC approves appointment of chairman and managing director
 ( Corporate News - 26-Mar-25   12:11 )
  REC consolidated net profit rises 23.21% in the December 2024 quarter
 ( Results - Announcements 06-Feb-25   18:02 )
  Board of REC approves market borrowing programme for FY 2026
 ( Corporate News - 26-Mar-25   12:07 )
  REC Ltd soars 2.42%, Gains for third straight session
 ( Hot Pursuit - 31-Jan-25   13:05 )
  REC Q3 PAT climbs 23% YoY to Rs 4,076 cr; declares dividend of Rs 4.30/sh
 ( Hot Pursuit - 06-Feb-25   16:00 )
  REC Directorate changes
 ( Corporate News - 02-Nov-24   11:21 )
  Nifty hovers near 24,150 mark; financial services shares advance
 ( Market Commentary - Mid-Session 01-Jul-24   14:37 )
  REC Ltd spurts 0.45%, rises for fifth straight session
 ( Hot Pursuit - 09-Jul-24   13:01 )
  REC schedules board meeting
 ( Corporate News - 31-Jan-25   11:32 )
  REC announces incorporation of two step-down subsidiaries
 ( Corporate News - 18-Nov-24   18:46 )
Other Stories
  LMW schedules board meeting
  03-Jul-25   09:15
  Julien Agro Infratech announces board meeting date
  03-Jul-25   09:15
  Alembic Pharmaceuticals announces acquisition of Utility Therapeutics
  03-Jul-25   09:15
  Shriram Asset Mgt. Company schedules AGM
  03-Jul-25   09:14
  Ideaforge Technology to convene AGM
  03-Jul-25   09:14
  D-Link (India) to announce Quarterly Result
  03-Jul-25   09:14
  Tuni Textile Mills to conduct board meeting
  03-Jul-25   09:14
  Biocon Biologics receives EU marketing authorisation for Vevzuo® and Evfraxy® biosimilars of Denosumab
  03-Jul-25   09:12
  Shakti Pumps launches QIP issue
  03-Jul-25   09:08
  Jai Mata Glass to conduct board meeting
  02-Jul-25   19:12
Back Top